Incidence of brain metastases in HER2+ gastric or gastroesophageal junction adenocarcinoma

Acta Oncol. 2015 Nov;54(10):1833-5. doi: 10.3109/0284186X.2015.1011757. Epub 2015 Mar 10.

Affiliations

¹ a Medical Oncology, Centre Eugene Marquis , Rennes , France.
² b Anatomo-pathology Unit, University Hospital Pontchaillou , Rennes , France.
³ c Inserm UMR991 , Rennes , France.
⁴ e Gastroenterology Unit, Saint Malo General Hospital , St Malo , France.
⁵ d Gastroenterology Unit, University Hospital Pontchaillou , Rennes , France.

PMID: 25753188
DOI: 10.3109/0284186X.2015.1011757

No abstract available

Publication types

Letter

MeSH terms

Adenocarcinoma / chemistry*
Adenocarcinoma / genetics
Adenocarcinoma / secondary*
Adult
Aged
Aged, 80 and over
Brain Neoplasms / secondary*
Disease-Free Survival
Esophagogastric Junction*
Female
Gene Amplification
Humans
Male
Middle Aged
Peritoneal Neoplasms / secondary*
Receptor, ErbB-2 / analysis*
Receptor, ErbB-2 / genetics
Retrospective Studies
Stomach Neoplasms / chemistry*
Stomach Neoplasms / genetics
Stomach Neoplasms / pathology*
Survival Rate
Young Adult

Substances

ERBB2 protein, human
Receptor, ErbB-2